Allen Mooney & Barnes Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9M | Buy |
85,492
+910
| +1% | +$169K | 2.61% | 10 |
|
|
2025
Q1 | $17.7M | Buy |
84,582
+411
| +0.5% | +$86.1K | 2.88% | 6 |
|
|
2024
Q4 | $15M | Sell |
84,171
-433
| -0.5% | -$76.9K | 2.52% | 10 |
|
|
2024
Q3 | $16.7M | Sell |
84,604
-2,527
| -3% | -$499K | 2.84% | 9 |
|
|
2024
Q2 | $14.9M | Buy |
87,131
+364
| +0.4% | +$62.4K | 2.67% | 8 |
|
|
2024
Q1 | $14.5M | Sell |
86,767
-1,181
| -1% | -$198K | 2.79% | 8 |
|
|
2023
Q4 | $13.6M | Buy |
87,948
+1,275
| +1% | +$198K | 2.59% | 9 |
|
|
2023
Q3 | $12.9M | Buy |
86,673
+3,242
| +4% | +$483K | 2.75% | 6 |
|
|
2023
Q2 | $11.2M | Buy |
83,431
+1,121
| +1% | +$151K | 2.49% | 10 |
|
|
2023
Q1 | $13.1M | Buy |
82,310
+982
| +1% | +$157K | 3.14% | 6 |
|
|
2022
Q4 | $13.1M | Buy |
81,328
+315
| +0.4% | +$50.9K | 3.16% | 3 |
|
|
2022
Q3 | $10.9M | Buy |
81,013
+2,572
| +3% | +$345K | 2.91% | 6 |
|
|
2022
Q2 | $12M | Buy |
78,441
+837
| +1% | +$128K | 3.08% | 4 |
|
|
2022
Q1 | $12.6M | Buy |
+77,604
| New | +$12.6M | 2.79% | 5 |
|